======= TAF10 ======= == Gene Information == * **Official Symbol**: TAF10 * **Official Name**: TATA-box binding protein associated factor 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6881|6881]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q12962|Q12962]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600475|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: TAFs are components of the transcription factor IID (TFIID) complex, PCAF histone acetylase complex and TBP-free TAFII complex (TFTC). TIIFD is a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. |TFIID 30kDa| |PCAF complex| |STAGA complex| |hepatocyte differentiation| |RNA polymerase II general transcription initiation factor activity| |transcription factor TFTC complex| |RNA polymerase binding| |histone deubiquitination| |transcription factor TFIID complex| |estrogen receptor binding| |histone H3 acetylation| |histone acetyltransferase activity| |multicellular organism growth| |histone acetylation| |internal peptidyl-lysine acetylation| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |regulation of DNA binding| |liver development| |hepaticobiliary system development| |protein acetylation| |transcription initiation from RNA polymerase II promoter| |regulation of signal transduction by p53 class mediator| |protein acylation| |DNA-templated transcription, initiation| |mitotic cell cycle phase transition| |cell cycle phase transition| |protein deubiquitination| |protein modification by small protein removal| |peptidyl-lysine modification| |protein homooligomerization| |enzyme binding| |histone modification| |covalent chromatin modification| |regulation of binding| |developmental growth| |growth| |gland development| |transcription by RNA polymerase II| |protein complex oligomerization| |mitotic cell cycle process| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |epithelial cell differentiation| |mitotic cell cycle| |perinuclear region of cytoplasm| |chromatin organization| |cellular protein-containing complex assembly| |peptidyl-amino acid modification| |apoptotic process| |protein modification by small protein conjugation or removal| |cell cycle process| |programmed cell death| |chromosome organization| |cell death| |nucleobase-containing compound biosynthetic process| |epithelium development| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |proteolysis| |organic cyclic compound biosynthetic process| |cell cycle| |DNA binding| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |tissue development| |macromolecule biosynthetic process| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.71| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.78| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.91| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.1| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.17| |[[:results:exp482|Fas-L 44ng/ml R08 exp482]]|2.19| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 116/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|3/28| |blood|6/28| |bone|4/25| |breast|5/33| |central nervous system|10/56| |cervix|1/4| |colorectal|2/17| |esophagus|2/13| |fibroblast|0/1| |gastric|3/15| |kidney|2/21| |liver|2/20| |lung|13/75| |lymphocyte|2/14| |ovary|5/26| |pancreas|0/24| |peripheral nervous system|5/16| |plasma cell|8/15| |prostate|0/1| |skin|4/24| |soft tissue|2/7| |thyroid|1/2| |upper aerodigestive|1/22| |urinary tract|8/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1420 * **Expression level (log2 read counts)**: 5.49 {{:chemogenomics:nalm6 dist.png?nolink |}}